Cer (d18:1/23:0)
Cer (d18:1/23:0) is a ceramide (sphingolipid). The level of Cer (d18:1/23:0) increases in coronary heart disease patients exposed to Metformin. The level of Cer (d18:1/23:0) is elevated in Chinese prediabetic and type 2 diabetic patients, and positively correlates with fasting blood glucose levels. Cer (d18:1/23:0) can be used in studies related to coronary heart disease, prediabetes and type 2 diabetes.
For research use only. We do not sell to patients.
- CAS No.: 67605-84-9
- Formula: C41H81NO3
- Molecular Weight:636.10
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Endogenous Metabolite Isoforms
More
Biological Activity
|
Human Endogenous Metabolite |
Chemical Information
-
CAS No. 67605-84-9
-
Molecular Weight 636.10
-
Formula C41H81NO3
-
SMILES
[C@@H](NC(CCCCCCCCCCCCCCCCCCCCCC)=O)([C@@H](/C=C/CCCCCCCCCCCCC)O)CO
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Li X, et al. Association of plasma ceramides with short-term and lifetime risk of MACE in coronary atherosclerotic heart disease patients: a prospective cohort study. BMJ Open. 2025;15(10):e094100. Published 2025 Oct 21. [Content Brief]
[3]. Yang J, et al. Integrated lipids biomarker of the prediabetes and type 2 diabetes mellitus Chinese patients. Front Endocrinol (Lausanne). 2023;13:1065665. Published 2023 Jan 20. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)